Fingerprint
Dive into the research topics of 'Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: Secondary analysis of the reduction by dutasteride of prostate cancer events (REDUCE) trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically